Evidence map›Paper›PMID 25346592›Full record

ArticlePsoriasis forum2010

Which Psoriasis Patients Develop Psoriatic Arthritis?

Kristine Busse, Wilson Liao

Abstract read
In one paragraph

Article in Psoriasis forum, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. State of the Art Review on the Treatment of Psoriatic Disease.Mediterranean journal of rheumatology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. IL-36 in chronic inflammation and fibrosis - bridging the gap?The Journal of clinical investigation · 2021
    Review
  13. DNA Methylation Patterns in CD8Frontiers in cell and developmental biology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Homocysteine and psoriasis.Bioscience reports · 2019
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kristine BusseDepartment of Dermatology and Psoriasis Treatment Center, University of California-San Francisco, San Francisco, California.
Wilson LiaoDepartment of Dermatology and Psoriasis Treatment Center, University of California-San Francisco, San Francisco, California.

Funding

Genetic Analysis of the TNF Pathway in PsoriasisK08AR057763 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIAO, WILSON · 2010 to 2014
$599k
NIAMS NIH HHS K08 AR057763
6 · The paper itself

Abstract

Psoriatic arthritis is a major comorbidity of psoriasis that significantly impairs quality of life and physical function. Because skin lesions classically precede joint symptoms, dermatologists are in a unique position to identify patients at risk for psoriatic arthritis before irreversible joint damage occurs. Here we review the literature to identify the clinical and genetic factors most highly associated with development of psoriatic arthritis, with the goal of assisting dermatologists in risk-stratifying their psoriasis patients.

Indexed as

clinical factorsgenetic factorsjoint damagepsoriatic arthritis

Identifiers

PMID25346592
PMCPMC4206220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.